Admission Date:  [**2156-12-27**]              Discharge Date:   [**2156-12-31**]  Date of Birth:  [**2082-2-26**]             Sex:   F  Service: MEDICINE  Allergies: Penicillins / Aspirin  Attending:[**First Name3 (LF) 5827**] Chief Complaint: Shortness of Breath  Major Surgical or Invasive Procedure: none  History of Present Illness: 74yo F with HTN, DM, CVA, CRI and hx of frequent falls s/p ORIF [**11-30**] who presented from her NH ([**Hospital3 2558**]) because she was noted to be unresponsive with pulse ox of 64%.
The pt was given ASA and BB IV upon arrival in the ED for her sob.
The pt was found to have a RUL infiltrate on CXR and was given ceftriaxone 1 gm IV x 1 and azithro 500 mg IV x1.
Pt noted to be hypertensive with SBP up to 200s and was given metoprolol 5 mg IV x3.
The pt was then given solumedrol and benadryl 25mg once IV in the ED for presumed allergic reaction and transferred to the ICU for further management.
In the [**Hospital Unit Name 153**], the pt reports worsening of herbreathing but denied any overt chest pain, palpitations, abdominal pain, n/v/d.
HEENT: EOMI, anicteric, pupils contricted, muddy sclerae, dry MM, white cereal noted in back of OP Neck: no LAD, no JVD, no bruits CV: rrr, S1, S2, no m/r/g appreciated Chest: bibasilar rales, mild end expiratory diffuse wheezes, decreased BS throughout, no dullness to percussion Abd: obese, soft, NT, ND, BS+ Ext: wwp, 2+pitting in LLE up to knee, staples on L thigh c/d/i, full DP/PT pulses Neuro: CN II-XII grossly intact, grip strength 4-/5 BL, 2+hip extension (unclear if pt was following commands)   Pertinent Results: Labs on Admission [**2156-12-27**] 10:00AM URINE  COLOR-Straw APPEAR-Hazy SP [**Last Name (un) 155**]-1.009 [**2156-12-27**] 10:00AM URINE  BLOOD-SM NITRITE-NEG PROTEIN-100 GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-8.0 LEUK-MOD [**2156-12-27**] 10:00AM URINE  RBC-[**2-13**]* WBC->50 BACTERIA-MOD YEAST-NONE EPI-[**5-21**] RENAL EPI-0-2 [**2156-12-27**] 10:00AM URINE  3PHOSPHAT-FEW [**2156-12-27**] 09:55AM   GLUCOSE-220* UREA N-57* CREAT-2.8* SODIUM-134 POTASSIUM-5.4* CHLORIDE-100 TOTAL CO2-24 ANION GAP-15 [**2156-12-27**] 09:55AM   ALT(SGPT)-26 AST(SGOT)-26 CK(CPK)-34 ALK PHOS-232* AMYLASE-56 TOT BILI-0.3 [**2156-12-27**] 09:55AM   LIPASE-67* [**2156-12-27**] 09:55AM   cTropnT-0.16* [**2156-12-27**] 09:55AM   CK-MB-NotDone [**2156-12-27**] 09:55AM   ALBUMIN-3.4 [**2156-12-27**] 09:55AM   WBC-11.7* RBC-3.50* HGB-10.0* HCT-31.0* MCV-89 MCH-28.6 MCHC-32.3 RDW-14.5 [**2156-12-27**] 09:55AM   NEUTS-89.0* LYMPHS-7.8* MONOS-2.3 EOS-0.7 BASOS-0.1 [**2156-12-27**] 09:55AM   PLT COUNT-682*# [**2156-12-27**] 09:55AM   PT-13.5* PTT-21.9* INR(PT)-1.2 .
# Anaphylaxis: Given the patient's allergy to penicillin and tongue swelling after the administration of ceftriaxone, there was concern that she was having an anaphylactic reaction.
The patient received Solemdrol and benadryl.
She was initially treated with Azithromycin and ceftriaxone.
However given her adverse reaction to the ceftriaxone, this was discontinued and the patient was started on Vancomycin.
At the time of discharge the patient was being treated with Levofloxacin.
However, the patient had been maintained on Lovenox.
#HTN: The patient was maintained on Lopressor, Imdur and Hydralazine.
Her hydralazine was increased to 50 TID because of elevated pressures.
CVA prevention: Tight glycemic and BP control was maintained.
The patient also received a statin.
With low urine outputs she received boluses and diuresed appropriately.
Following her ORIF her creatinine has ranged from 2.8 to 3.2.
Diabetes: The patient was maintained on insulin sliding scale.
She was maintained on iron supplements, epogen and her stools were guaiac negative.
The patient did not require blood transfusions.
The patient was seen by speech and swallow and they recommended thin liquids and soft foods.
She also received kayexylate for hyperkalemia.
Acetaminophen 325 mg Tablet Sig: 1-2 Tablets PO Q4-6H (every 4 to 6 hours) as needed.
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2  times a day).
Pantoprazole 40 mg Tablet, Delayed Release (E.C.)
Diltiazem HCl 240 mg Capsule, Sustained Release Sig: One (1) Capsule, Sustained Release PO DAILY (Daily).
Atorvastatin 20 mg Tablet Sig: 1.5 Tablets PO DAILY (Daily).
Olanzapine 5 mg Tablet Sig: One (1) Tablet PO HS (at bedtime).
Epoetin Alfa 3,000 unit/mL Solution Sig: 3000 (3000) units Injection QMOWEFR (Monday -Wednesday-Friday).
Isosorbide Mononitrate 30 mg Tablet Sustained Release 24HR Sig: Three (3) Tablet Sustained Release 24HR PO DAILY (Daily).
Hydralazine 25 mg Tablet Sig: Three (3) Tablet PO Q6H (every  6 hours).
Enoxaparin 30 mg/0.3 mL Syringe Sig: Thirty (30) mg Subcutaneous Q24H (every 24 hours) for 4 months.
Ipratropium Bromide 0.02 % Solution Sig: One (1) neb Inhalation Q6H (every 6 hours).
Metoprolol Tartrate 50 mg Tablet Sig: Three (3) Tablet PO TID (3 times a day).
Aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Pantoprazole 40 mg Tablet, Delayed Release (E.C.)
Isosorbide Mononitrate 30 mg Tablet Sustained Release 24HR Sig: Three (3) Tablet Sustained Release 24HR PO DAILY (Daily).
Metoprolol Tartrate 50 mg Tablet Sig: Three (3) Tablet PO TID (3 times a day).
Epoetin Alfa 4,000 unit/mL Solution Sig: One (1)  Injection QMOWEFR (Monday -Wednesday-Friday).
Olanzapine 5 mg Tablet Sig: One (1) Tablet PO HS (at bedtime).
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Ipratropium Bromide 0.02 % Solution Sig: One (1)  Inhalation Q6H (every 6 hours).
Albuterol Sulfate 0.083 % Solution Sig: One (1)  Inhalation Q6H (every 6 hours) as needed.
Enoxaparin 30 mg/0.3 mL Syringe Sig: One (1)  Subcutaneous Q24H (every 24 hours).
Insulin Lispro (Human) 100 unit/mL Solution Sig: ASDIR Subcutaneous ASDIR (AS DIRECTED).
Acetaminophen 325 mg Tablet Sig: One (1) Tablet PO Q4-6H (every 4 to 6 hours) as needed.
Levofloxacin 250 mg Tablet Sig: One (1) Tablet PO Q48H (every 48 hours) for 10 days.
Ferrous Sulfate 325 (65) mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Atorvastatin 10 mg Tablet Sig: Three (3) Tablet PO DAILY (Daily).
Hydralazine 50 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 hours).
Vancomycin in Dextrose 1 g/200 mL Piggyback Sig: One (1) Intravenous  Q48H (every 48 hours) for 5 days.
Diltiazem HCl 240 mg Tablet Sustained Release 24HR Sig: One (1) Tablet Sustained Release 24HR PO once a day.
Disp:*30 Tablet Sustained Release 24HR(s)* Refills:*2*   Discharge Disposition: Extended Care  Facility: [**Hospital3 2558**] - [**Location (un) **]  Discharge Diagnosis: -Community Acquired Pneumonia -Urinary Tract Infection -Anaphylaxis   Discharge Condition: Good Vitals stable Patient eating   Discharge Instructions: Please seek medical services immediately if you should experience and shortness of breath, fevers, chills or any other worrisome symptom.
Please continue taking your medications as prescribed.
